Delivery Order SPE2DE24DA010-SPE2D625F3AK4
- Not listed
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a $9,500 fixed-price delivery order with economic price adjustment for the AVEIR leadless pacemaker system on September 12, 2025. The contract, issued by the Defense Logistics Agency's Medical Supply Chain organization, will be performed in Santa Clara, California, with an ultimate completion date of September 17, 2025. This delivery order was awarded without a set-aside designation, indicating full and open...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, has been awarded a $28,350 fixed-price delivery order with economic price adjustment for the supply of Aveir Leadless Pacemakers. The award, issued on June 4, 2025, is set to conclude by June 10, 2025, and represents a child contract under Abbott Laboratories Inc.'s parent entity. The contract was awarded without set-aside designation, indicating full and open competition, and will be performed in Santa Clara, California. The...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a fixed-price delivery order valued at $24,350.00 by the Defense Logistics Agency's Medical Supply Chain on September 10, 2025, with an ultimate completion date of September 15, 2025. The contract, which involves no set-aside designation and therefore represents full and open competition, is for the delivery of the Aveir Leadless Pacemaker system to be performed at the contractor's facility in Santa Clara,...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, has been awarded a $18,600 fixed-price delivery order with economic price adjustment for Aveir Leadless Pacemakers, with an ultimate completion date of July 23, 2025. The contract was awarded without a set-aside designation on July 18, 2025, indicating full and open competition. Performance will take place in Santa Clara, California, with funding provided by the Defense Logistics Agency's Medical Supply Chain division, which...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, has been awarded a fixed-price delivery order valued at $49.8K by the Department of Defense's Medical Supply Chain for the delivery of Aveir Leadless Pacemakers. The contract, awarded on August 1, 2025, with an ultimate completion date of August 6, 2025, will be performed in Santa Clara, California. This delivery order was awarded without a set-aside designation, indicating full and open competition. The award represents a...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a delivery order valued at $8,750 by the Defense Logistics Agency's Medical Supply Chain on August 11, 2025, with an ultimate completion date of August 14, 2025. The contract utilizes a fixed-price pricing structure with economic price adjustment provisions and is not subject to any set-aside designation, indicating full and open competition. The award covers delivery of the AVEIR Leadless Pacemaker to the place...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a fixed-price delivery order valued at $28,350 by the Defense Logistics Agency's Medical Supply Chain on August 26, 2025, with an ultimate completion date of August 29, 2025. The contract, which was not set-aside and available through full and open competition, is for the delivery of Aveir Leadless Pacemakers to be performed at Abbott's location in Santa Clara, California. This delivery order represents a...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a fixed-price delivery order valued at $28,350.00 by the Defense Logistics Agency's Medical Supply Chain on August 18, 2025, with an ultimate completion date of August 21, 2025. The contract, identified as AVEIR (a reference to Abbott's Aveir Leadless Pacemaker technology), will be performed in Santa Clara, California, and was awarded without a set-aside designation, indicating full and open competition. This...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a fixed-price delivery order with economic price adjustment valued at $10,500 by the Medical Supply Chain, a defense-focused federal agency, on September 12, 2025. The contract, designated as AVEIR (likely referencing Abbott's Aveir Leadless Pacemaker technology), involves delivery to Santa Clara, California, with an ultimate completion date of September 17, 2025. This award was made without a set-aside designation,...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a fixed-price delivery order valued at $14,850 by the Department of Defense's Medical Supply Chain on July 24, 2025, with an ultimate completion date of July 29, 2025. The contract is for the AVEIR product line and will be performed in Santa Clara, California. This delivery order was issued without a set-aside designation, indicating full and open competition. The award represents a task order under Abbott's broader...
- SPE2DE24DA010Indefinite Delivery Contract
- SPE2DE24DA010-SPE2D625F3AK4Delivery Order
Abbott Laboratories Inc., through its Abbott Vascular Inc. division, has been awarded a $29.7K fixed-price delivery order with economic price adjustment authority for the AVEIR leadless pacemaker system. The award, issued on June 18, 2025, with an ultimate completion date of June 24, 2025, represents a child contract under Abbott's broader relationship with the Defense Logistics Agency's Medical Supply Chain. The contract involves delivery to Santa Clara, California, and was awarded through full and open competition with no set-aside designation. This delivery order supports the Department of Defense's medical supply requirements through the Defense Logistics Agency's Medical Supply Chain function. Abbott Vascular has established itself as a critical supplier of advanced cardiovascular technologies to federal healthcare systems, and the AVEIR leadless pacemaker is among its portfolio of sophisticated cardiac devices previously supplied to federal agencies. The fixed-price structure with economic price adjustment provisions ensures cost stability while allowing for inflation adjustments, consistent with Abbott's typical federal contracting arrangements for specialized medical device delivery.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $29.7k | 6/18/25 |